VOYA Investment Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.8K | Buy |
34,776
+3,462
| +11% | +$8.34K | ﹤0.01% | 2522 |
|
|
2025
Q1 | $69.2K | Sell |
31,314
-315,409
| -91% | -$697K | ﹤0.01% | 2502 |
|
|
2024
Q4 | $1.89M | Buy |
346,723
+267,485
| +338% | +$1.46M | ﹤0.01% | 1321 |
|
|
2024
Q3 | $658K | Sell |
79,238
-38,193
| -33% | -$317K | ﹤0.01% | 1850 |
|
|
2024
Q2 | $841K | Sell |
117,431
-71,386
| -38% | -$511K | ﹤0.01% | 1718 |
|
|
2024
Q1 | $1.64M | Buy |
188,817
+109,497
| +138% | +$949K | ﹤0.01% | 1423 |
|
|
2023
Q4 | $520K | Sell |
79,320
-957
| -1% | -$6.27K | ﹤0.01% | 2057 |
|
|
2023
Q3 | $803K | Sell |
80,277
-859
| -1% | -$8.59K | ﹤0.01% | 1764 |
|
|
2023
Q2 | $1.01M | Sell |
81,136
-75,080
| -48% | -$933K | ﹤0.01% | 1661 |
|
|
2023
Q1 | $2.19M | Buy |
156,216
+4,683
| +3% | +$65.6K | ﹤0.01% | 1318 |
|
|
2022
Q4 | $2.17M | Buy |
151,533
+84,274
| +125% | +$1.21M | ﹤0.01% | 1288 |
|
|
2022
Q3 | $1.72M | Buy |
67,259
+20,243
| +43% | +$517K | ﹤0.01% | 1383 |
|
|
2022
Q2 | $1.34M | Sell |
47,016
-6,397
| -12% | -$182K | ﹤0.01% | 1265 |
|
|
2022
Q1 | $1.88M | Sell |
53,413
-1,009
| -2% | -$35.6K | ﹤0.01% | 1141 |
|
|
2021
Q4 | $2.28M | Buy |
54,422
+21,769
| +67% | +$912K | ﹤0.01% | 1102 |
|
|
2021
Q3 | $1.6M | Buy |
32,653
+7,753
| +31% | +$380K | ﹤0.01% | 1291 |
|
|
2021
Q2 | $1.04M | Buy |
24,900
+6,214
| +33% | +$259K | ﹤0.01% | 1600 |
|
|
2021
Q1 | $666K | Buy |
+18,686
| New | +$666K | ﹤0.01% | 1855 |
|